Table 1.
Baseline Characteristics of Participants Data are Presented as N (%), Except for Displaying Age as Mean [Standard Deviation (SD)].
| Participants characterisicts (n=470) | values | |
|---|---|---|
| Age y.o., mean (SD) | 41.0 (11.9) | |
| Male, n (%) | 118 (25) | |
| Generation | ||
| 20-29 y.o., n (%) | 108 (23) | |
| male, n (%) | 20 (19) | |
| 30-39 y.o., n (%) | 105 (22) | |
| male, n (%) | 35 (33) | |
| 40-49 y.o., n (%) | 128 (27) | |
| male, n (%) | 28 (22) | |
| 50-59 y.o., n (%) | 105 (22) | |
| male, n (%) | 27 (26) | |
| 60 y.o -., n (%) | 24 (5) | |
| male, n (%) | 8 (33) | |
| Hypertension, n (%) * | 20 (4) | |
| Dyslipidemia, n (%) * | 8 (1) | |
| Collagen disease, n (%) * | 5 (1) | |
| Bronchial asthma, n (%) * | 3 (1) | |
| Diabetes mellitus, n (%) * | 2 (1) | |
| Endocrine disease, n (%) * | 2 (1) | |
| Depression, n (%) * | 3 (1) | |
| Previous history of malignancy disease, n (%) † | 3 (1) | |
| Immunosuppressant therapy, n (%) | 1 (1) |
* Prescribed as requiring year-round medication. † Included a participant after a lung cancer surgery and two participants after breast cancer surgery.